Stock Price Quote

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01020Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE2039.75-31.35 (-1.51 %)
PREV CLOSE ( ) 2071.10
OPEN PRICE ( ) 2069.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 14471
TODAY'S LOW / HIGH ( )2027.15 2069.40
52 WK LOW / HIGH ( )1786.05 2767.1
NSE2039.05-32.2 (-1.55 %)
PREV CLOSE( ) 2071.25
OPEN PRICE ( ) 2055.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2039.05 (2504)
VOLUME 763092
TODAY'S LOW / HIGH( ) 2029.35 2073.95
52 WK LOW / HIGH ( )1785.4 2766.2
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-10 1949
Management Info
Premchand Godha - Chairman Premchand Godha - Managing Director
Registered Office

Address 48 , Kandivli Industrial Estate,Kandivli (West), ,
Mumbai,
Maharashtra-400067

Phone 022- 66474444/62106050

Email investors@ipca.com

Website www.ipca.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX

NEWS

24Nov Ipca Laboratories informs about outcom
Pursuant to Regulation 30 of the Securities and Exchange Board of India..
24Nov Ipca Laboratories acquires around 26%
Ipca Laboratories has acquired 26.574% of the paid-up share capital of L..
24Nov Ipca Laboratories jumps on acquiring a
Ipca Laboratories is currently trading at Rs. 2070.90, up by 13.20 point..
17Nov Ipca Laboratories informs about analys
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
29Oct IPCA Laboratories informs about credit
IPCA Laboratories has informed that CRISIL has re-affirmed its rating fo..

Financials

in Millions
QTR Sep 21 ANNUAL 21
Net Profit2576.411407.7
Gross Profit 3221.2 13799.6
Operating Profit 3740.915758.2
Net Sales 14238.451391.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Medicamen Biotech (BSE)
peergroup  699.50 (16.65%)
M.Cap ( in Cr)854.55
Hester Biosciences (BSE)
peergroup  2346.25 (4.12%)
M.Cap ( in Cr)1995.92
Kwality Pharma (BSE)
peergroup  905.50 (5.00%)
M.Cap ( in Cr)939.56
Glaxosmithkline Phar (BSE)
peergroup  1732.10 (2.23%)
M.Cap ( in Cr)29342.82
Unichem Lab (BSE)
peergroup  256.05 (14.69%)
M.Cap ( in Cr)1802.74

Shareholding Pattern

NON-INSTITUTION 9.8%
PROMOTERS 46.29%
FI/BANKS/INSURANCE 3.18%
MUTUAL FUNDS/UTI 21.82%
GOVERNMENT 0.22%
FII 0%

About Ipca Laboratories Ltd.

Ipca Laboratories Ltd. was incorporated in the year 1949. Its today's share price is 2039.75. Its current market capitalisation stands at Rs 25874.66 Cr. In the latest quarter, company has reported Gross Sales of Rs. 51391.6 Cr and Total Income of Rs.52427.1 Cr. The company's management includes Harish P Kamath, Kamal Kishore Seth, Manisha Premnath, Dev Parkash Yadava, Anand T Kusre, Prashant Godha, Pranay Godha, Ajit Kumar Jain, Premchand Godha, Premchand Godha.

It is listed on the BSE with a BSE Code of 524494 , NSE with an NSE Symbol of IPCALAB and ISIN of INE571A01020. It's Registered office is at 48 , Kandivli Industrial Estate,Kandivli (West), Mumbai-400067, Maharashtra. Their Registrars are ACC Ltd. It's auditors are GM Kapadia & Co, Natvarlal Vepari & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)